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The proteinase responsible for bone collagen degradation in osteo-resorption was examined. The bone pit formation induced by parathyroid 
hormone (PTH) was markedly suppressed by leupeptin, E-64 and cystatin A, while no inhibition was observed by CA-074, a specific inhibitor of 
cathepsin B. Pig leucocyte cysteine proteinase inhibitor (PLCPI), a specific inhibitor of cathepsin L, and chymostatin, a selective inhibitor of 
cathepsin L, completely inhibited the pit formation. Cathepsin L activity in osteoclasts was much higher than the other cathepsin activities. Serum 
calcium in rats placed on a low calcium diet was decreased by treatment of E-64 or cystatin A, but not by CA-074. These findings suggest hat 
cathepsin L is the main proteinase responsible for bone collagen degradation. 
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1. INTRODUCTION 
The osteoclasts are well known to be mainly responsi- 
ble for the degradation of the organic matrix (mainly 
collagen fibers) during the process of bone resorption 
[l-4]. Lysosomal proteinases, possibly a certain cysteine 
proteinase, in osteoclasts are thought to play an impor- 
tant role in the osseous collagenolysis [2,4-81. Cathep- 
sins such as cathepsins B, L and N have been shown to 
be able to efficiently degrade collagen at acidic pH [9- 
121. A comparison of collagenolytic activity of these 
cathepsins has indicated that cathepsin L is particularly 
strong [4,13,14]. Vaes and his colleagues have shown 
that there is no correlation between the resorption of 
cultured mouse bone cells and their secretion of collage- 
nase, while good correlations exist between bone re- 
sorption and the excretion of cathepsin B induced by 
parathyroid hormone (PTH) [6,15]. Furthermore, they 
also demonstrated that several inhibitors of cysteine 
proteinases, such as leupeptin, antipain, tosyl-lysyl 
chloromethane (Tos-Lys-CH,Cl), benzyl-oxycarbonyl- 
phenylalanyl-alanyl-diazomethane (Z-Phe-Ala-CHN,) 
and trans-epoxysuccinyl-L-leucylamido-(4-guanidino)- 
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butane (E-64), markedly inhibited the resorption in- 
duced by PTH or heparin in cultured mouse bone cells 
[4-61. When intraperitoneal injection of E-64 or leu- 
peptin was given to rats, their serum calcium levels and 
urinary excretion of hydroxyproline significantly de- 
creased 3 and 6 h after administration of the drug [6]. 
E-64 and leupeptin [I 6-201 are very powerful inhibitors 
of all kinds of cysteine proteinases including calpains. 
These facts suggest he possibility that among lysosomal 
collagenolytic ysteine proteinases, in particular cathep- 
sins B and L in osteoclasts may play a major role in the 
bone resorption. However, the particular proteinase re- 
sponsible for the degradation of the bone collagen has 
not been decided yet. 
This paper reports the proteinase responsible for 
bone collagen degradation in osteoclastic bone resorp- 
tion. We investigated the inhibition of bone resorption 
by various type of inhibitors, such as, pig leucocyte 
cysteine proteinase inhibitor (PLCPI) [21], a specific 
inhibitor of cathepsin L, CA-074 [22], a specific inhibi- 
tor of cathepsin B, and other inhibitors of cysteine pro- 
teinases. 
2. EXPERIMENTAL 
2.1. Materials 
Z-Phe-Arg-MCA, Z-Arg-Arg-MCA and Arg-MCA were purchased 
from the Peptide Institute (Osaka, Japan). E-64-a and CA-074 were 
kindly supplied from Taisho Pharmaceutical Co., Saitama, Japan. 
PLCPI and recombinant cystatin A were prepared as described previ- 
ously [2 1,231. Leupeptin, chymostatin, pepstatin and pronase E were 
purchased from Sigma Chemical Co. (St. Louis, MO). Fetal bovine 
serum (FBS) was from Gibco (Grand Island, NY), and human 
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PTH(l-34) was from Peninsula Laboratories Inc. (Belmond, CA). All 
other chemicals were of analytical grade. Rat liver cathepsins L and 
B were purified according to the published procedure [22,24,25]. Spra- 
gue-Dawley rats (l-2 days old) used for preparation of unfractionated 
bone cells, and male Wistar rats (80-100 g) were obtained from Char- 
les River, Japan. Ivory slices (150 pm thick) were punched out as 
circles 6 mm in diameter, sonicated, and sterilized in 75% ethanol. Low 
calcium diet (Ca: 0.02-0.03%), a slightly modified Diet-l 1, was pur- 
chased from Nippon Clea (Osaka, Japan). OCPC calcium assay kit 
was from Wako Pure Chemicals Co. (Osaka, Japan). 
2.2. Metho& 
2.2.1. Enzyme assay 
Cathepsin activities were measured with Z-Phe-Arg-MCA at pH 5.5 
for cathepsin L and Z-Arg-Arg-MCA at pH 6.0 for cathepsin B as 
substrates respectively by the method of Barrett and Kirschke [26]. 
Inhibitors were preincubated with enzyme and 8 mM cysteine hydro- 
chloride for 3 min and then reactions were started by addition of the 
substrates. The activity of each enzyme was adjusted to 0.5 units (one 
unit expresses as the production of 1 prnol methylcoumarylamine p r 
min from 20 PM of substrate at 37’C). The fluorescence of 7-amino- 
4-methylcoumarin liberated from the substrate was monitored by a 
Hitachi fluorescence spectrometer. 
2.2.2. Assay of bone resorption 
Bone resorption was assessed according to the method of McSheehy 
and Chambers [27] with certain modifications. Unfractionated bone 
cells were prepared from tibiae, femora and humeri of 1-2 days old 
Sprague-Dawley rats. The bones were dissected free of soft tissues in 
iced tissue culture medium (PH 7.2) [alpha-minimum essential medium 
(a-MEM) (Flow Laboratories, McLean, VA) supplemented with 100 
IU per ml benzylpenicillin] containing 20 mM N-2-hydroxyethyl- 
piperazine-W-ethanesulfonic acid (HEPES). For preparation of bone 
cells the long bones were minced with scissors in the same medium. 
The suspension was then triturated with a wide bored plastic pipette. 
Two hundred ~1 of the suspension (1 x lo6 cells per ml) was added to 
each well of 96-well plate containing an ivory slice, and the cells were 
incubated at 37’C in a CO1 incubator (5% CO,:95% air) for 2 h. The 
slices were then rinsed with a-MEM and transferred to fresh medium 
containing 10% FBS, various concentrations of inhibitors and 50 nM 
of PTH, but not containing HEPES, and were incubated for 72 h. The 
cells were removed by vigorously washing with distilled water, and 
then the slices were stained with 0.1% Toluidine blue for 5 min. The 
total area of pits was measured under a light microscope to detect 
possible osteoclastic bone resorption. 
2.2.3. Cysteine proteinase activities in rat osteoclasts 
Rat osteoclasts were purified according to the method of Tezuka et 
al. [28]. After purification, 90% of cells were multinucleate and had 
tartrate-resistant acid phosphatase activity. The cell suspension in PBS 
was adjusted to a concentration of 7 x lo3 osteoclasts per ml. The cells 
were then destroyed by sonication, and after centrifugation, the cyste- 
ine proteinase activities were assayed as described above. Cathepsins 
L and B were measured by assay in the presence and absence of 1 x lo6 
M of CA-074 and cathepsin B was calculated as the CA-07Csensitive 
Z-Phe-Arg-MCA hydrolyzing activity; the rest of the activity was 
regarded as cathepsin L activity. Protein concentration in a superna- 
tant was determined by the BCA method (Pierce Chemical. Co., Rock- 
ford, IL) with bovine serum albumin as a standard. 
2.2.4. In vivo effects of cysteine proteinase inhibitor on serum calcium 
Male Wistar rats (SO-100 g) received low calcium diet for one week 
and then starved overnight. E-64-a and CA-074 at doses of 3 and 6 
mg per 100 g body weight, respectively, and cystatin A at a dose of 
8 mg per 100 mg body weight were injected intraperitoneally to these 
rats. Blood samples were collected at various times from tail vein 
under ether anesthesia fter the administration of drugs to determine 
serum calcium concentrations. Serum calcium was measured with 
OCPC assay reagent by the method of Conerty and Briggs [29]. 
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3. RESULTS AND DISCUSSION 
The effects of cysteine proteinase inhibitors on pit 
formation induced by PTH were investigated, and sup- 
pression of pit formation by various proteinase inhib- 
itors were compared in the relation with the inhibition 
profiles of cathepsins L and B activities shown in Table 
I. The number of resorptive pits was stimulated by 50 
nM of PTH to 3 times more than that of spontaneous 
group. E-64 and leupeptin markedly inhibited the re- 
sorption enhanced by PTH in the range of 1 x 10e8 to 
1 x low6 M, and also cystatin A [30-321 which strongly 
inhibits both cathepsins B and L, but does not inhibit 
calpain, exhibited in the dose-dependent manner at con- 
centrations ranging from 1 x lo-’ to 1 x 10e6 M, indi- 
cating that calpain does not participate in the bone 
resorption. Leupeptin is known to inhibit not only thiol 
proteinases but also some serine proteinases. However, 
aprotinin and soya-bean trypsin inhibitor, specific in- 
hibitors of serine proteinases, demonstrated no inhibi- 
tion on the bone pit formation [4,33]. Therefore, trypsin 
type serine proteinases are not involved in the bone 
resorption. 
Delaisse et al. reported that PTH-induced excretion 
of cathepsin B in cultures of embryonic mouse calvaria 
Table I 
Effects of proteinase inhibitors on the activities of cathepsin L and B, 
and pit formation 
Inhibitor Concentra- 
tion (M) 
Relative activity (%) 
Control 
Blank 
Leupeptin 
E-64 
CA-074 
Cystatin A 
Chymostatin 
PLCPI 
Pepstatin 
Cathepsin Cathepsin Bone 
L B resorption 
_ 100.0 100.0 100.0 + 19.4 
_ _ _ 31.2 f 9.81’” 
1 x lo-8 57.2 73.4 42.6 f 8.2” 
1 x 1o-7 8.3 14.4 45.1 f 14.6 
1 x 1o-6 3.2 3.5 28.0 ? 12.2b 
1 x lo-* 72.8 56.2 50.5 + 12.9” 
1 x lo-’ 37.2 3.4 40.9 + 13.3” 
1 x 1o-6 10.3 1.7 46.2 f 8.6” 
1 x lo-’ 100.2 2.2 94.2 + 26.9 
1 x 1o-6 98.3 1.0 73.1 f 29.7 
1 x lo-8 22.4 97.2 41.9 + 17.6” 
1 x lo-’ 9.8 44.7 31.2 f 9.7” 
1 x 1o-6 3.1 4.3 17.6 f 5.4b 
1 x 10-e 9.8 101.3 5.9 + O.lb 
1 x 10-8 94.4 114.3 73.1 f 7.5” 
1 x lo-’ 43.0 122.2 40.9 f 1.7” 
1 x 1o-6 4.7 124.8 0.1 f O.lb 
1 x 1o-5 103.3 104.7 104.4 f 8.8 
Enzyme assay: each value indicates the mean of 3 observations. Bone 
resorption: +Sponaneous (without PTH) bone resorption. Concen- 
tration of PTH was 50 nM. Each value indicates the mean + S.E.M. 
of 5-6 observations. 
aP < 0.05; bP < 0.01; significant difference from control group (Stu- 
dent’s c-test). 
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was closely correlated with the extent of bone resorption 
[6]. Therefore, to confirm the role of cathepsin B on 
bone resorption, we examined the effect of CA-074, a 
specific inhibitor of cathepsin B, on pit formation. The 
CA-074 did not inhibit pit formation, suggesting that 
cathepsin B did not participate in the osteoclastic bone 
resorption. 
Recently, Maciewicz et al. reported that collagens are 
degraded more extensively by cathepsin L than by other 
collagenolytic cathepsins [ 131. Dalaisse et al. also found 
cathepsin B, cathepsin L and a cathepsin L-like 70 kDa 
proteinase in a homogenate of mouse calvaria, showed 
collagenolytic activity [14]. In addition, in the present 
study chymostatin which inhibits cathepsin L but not 
cathepsin B, perfectly inhibited the resorption at a con- 
centration of 1 x 10e6 M. The PLCPI isolated from pig 
leucocytes [21], a specific inhibitor of cathepsin L, sup- 
pressed the formation of pits induced by PTH in a con- 
centration range of 1 x 10m8 to 1 x 10T6 M in a dose- 
dependent manner. PLCPI, cystatin A and chymostatin 
at concentration of 1 x 10m6 M inhibited not only PTH- 
induced pit formation, but also spontaneous pit forma- 
tion. These inhibition analyses clearly suggest that 
cathepsin L or cathepsin L-like proteinase is the main 
proteinase responsible for bone resorption. Moreover, 
it is possible to speculate that the endogenous cathepsin 
L inhibitors such as PLCPI and cystatins may partici- 
pate in the natural regulation of bone resorption phe- 
nomenon in physiological and pathological conditions. 
On the other hand, pepstatin, a specific inhibitor of 
aspartic proteinase, did not show any inhibitory effect 
on the pit formation. 
With respect to the distribution of cathepsin L in 
osteoclasts, immunohistochemically cathepsin L is de- 
tected not only in lysosomes [34] but also in extracellu- 
lar resorption lacunae [35]. The contents of various 
cysteine proteinases in osteoclasts were determined. Z- 
Phe- Arg-MCA, Z-Arg-Arg-MCA and Arg-MCA hy- 
drolytic activities by the purified rat osteoclasts were 
assayed as the corresponding activities to cathepsin L 
plus B, cathepsin B and cathepsin H, respectively. As 
shown in Table II, Z-Phe-Arg-MCA hydrolytic activity 
for cathepsin L plus B was found to be the highest, this 
Table II 
Cysteine proteinase activities in rat osteoclasts 
Inhibitor Cysteine proteinase activities 
Z-Phe-Arg-MCA Z-Arg-Arg-MCA Arg-MCA 
CuDlmg) olH/mg) OIIJmg) 
None 245.3 60.3 12.7 
CA-074f 192.7 4.2 _ 
Total protein in an extract of rat osteoclasts was 8.7 &ml. fconcen- 
tration of CA-074 was 1 x 10m6 M. 
Oh 3h 6h 
Control 
E-64 ; 3m@lOOg 
E-64 ; 6mg/l OUg 
CA-074 ; 3mgilOOg 
CA-074 ; Gmg/lOOg 
CystalinA ; 6mgIlOOg 
10h 
Time course 
Fig. 1. Effects of E-64, CA-074 and cystatin A on serum calcium levels 
in low calcium dietary rats. Each value indicates the mean f S.E.M. 
of 5 observations. **P C 0.01, *P < 0.05; significant difference from 
control group (Student’s t-test). 
activity being about 4 times higher than Z-Arg-Arg- 
MCA hydrolytic activity. The CA-074 inhibited only 
the part of cathepsin B activity in Z-Phe-Arg-MCA hy- 
drolytic activity, and virtually inhibited Z-Arg-Arg- 
MCA hydrolytic activity. Thus, the Z-Phe-Arg-MCA 
hydrolytic activity in the presence of CA-074 corre- 
sponds to the cathepsin L activity. On the other hand, 
Arg-MCA hydrolytic activity for cathepsin H was very 
weak. Therefore, osteoclasts contain large amounts of 
cathepsin L or cathepsin L-like proteinase, and this fact 
also supports the important role of collagenolytic activ- 
ity of cathepsin L on bone resorption. 
Moreover, the results of the pit formation in vitro 
reflex directly affects the serum calcium level derived 
from bone resorption in vivo. We examined the in vivo 
effects of E-64, cystatin A and CA-074 on serum cal- 
cium in low calcium dietary rats, and the results are 
shown in Fig. 1. The injection of E-64 at doses of 3 and 
6 mg/lOO g body weight to low calcium dietary rats 
resulted in significant decreases in the serum calcium 3 
and 6 h after the injection of the drug in a dose-depend- 
ent manner. Furthermore, cystatin A at a dose of 8 
mg/lOO g body weight significantly decreased calcium 
level in serum. When the cysteine proteinase activities 
in the extracts of femur bone were measured one hour 
after injection of E-64 or cystatin A were measured, all 
cysteine proteinases in femur bone are inhibited effec- 
tively. While, CA-074 did not affect the serum calcium 
level, although cathepsin B activity in the bone extract 
was specifically inhibited. From these results, it was 
reconfirmed in the in vivo system that the cathepsin L, 
rather than cathepsin B, play a central role in bone 
collagen degradation. 
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